U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
Investigational
144
US Approved Rx
37
Possibly Marketed Outside US
1
US Previously Marketed
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Primary Target
Receptor tyrosine-protein kinase erbB-2
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Highest Phase
Approved
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
Unknown
145
2015
5
2014
4
2024
4
2004
3
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Condition
Breast cancer
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Treatment Modality
Primary
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Originator
Genentech
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Protein
148
Concept
26
Structurally Diverse
5
Nucleic Acid
4
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
FDA UNII
183
NCI_THESAURUS
183
SMS_ID
169
CAS
159
INN
152
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Protein Type
MONOCLONAL ANTIBODY
126
MONOCLONAL ANTIBODY CONJUGATE
12
BISPECIFIC ANTIBODY
7
BISPECIFIC MONOCLONAL FRAGMENTS
1
MONOCLONAL ANTIBODY FUSION PROTEIN
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
25
MUSCULO-SKELETAL SYSTEM
1
NERVOUS SYSTEM
1
VARIOUS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
ANTINEOPLASTIC AGENTS
22
IMMUNOSUPPRESSANTS
4
DRUGS FOR TREATMENT OF BONE DISEASES
1
OTHER NERVOUS SYSTEM DRUGS
1
THERAPEUTIC RADIOPHARMACEUTICALS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
OTHER ANTINEOPLASTIC AGENTS
22
IMMUNOSUPPRESSANTS
4
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
1
OTHER NERVOUS SYSTEM DRUGS
1
OTHER THERAPEUTIC RADIOPHARMACEUTICALS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Monoclonal antibodies
21
Interleukin inhibitors
2
Selective immunosuppressants
2
Iodine (<sup>131</sup>I) compounds
1
Other antineoplastic agents
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
182
Salts, Hydrates, Esters, etc.
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Search results for
"Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent"
in
comments
(approximate match)
Showing
1 - 10
of
183
results
Search within data set
First page disabled
Previous page disabled
1
2
3
4
18
19
Next page
Next page
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
Zolbetuximab
MORE DETAILS
TF5MPQ8WGY
Subunit
1
(448) Similarity Search
Subunit
2
(448) Similarity Search
Subunit
3
(220) Similarity Search
Subunit
4
(220) Similarity Search
Export Data
Sequence Search
Subunit
1
(448) Similarity Search
Subunit
2
(448) Similarity Search
Subunit
3
(220) Similarity Search
Subunit
4
(220) Similarity Search
Status:
US Approved Rx (2024)
First approved in 2024
Class:
PROTEIN
Cosibelimab
MORE DETAILS
PNW7GBB44P
Subunit
1
(450) Similarity Search
Subunit
2
(450) Similarity Search
Subunit
3
(218) Similarity Search
Subunit
4
(218) Similarity Search
Export Data
Sequence Search
Subunit
1
(450) Similarity Search
Subunit
2
(450) Similarity Search
Subunit
3
(218) Similarity Search
Subunit
4
(218) Similarity Search
Status:
US Approved Rx (2024)
First approved in 2024
Class:
PROTEIN
TISLELIZUMAB
MORE DETAILS
0KVO411B3N
Subunit
1
(445) Similarity Search
Subunit
2
(445) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(445) Similarity Search
Subunit
2
(445) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2024)
First approved in 2024
Class:
PROTEIN
Zenocutuzumab
MORE DETAILS
AE72RB1W1X
Subunit
1
(453) Similarity Search
Subunit
2
(450) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(453) Similarity Search
Subunit
2
(450) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2024)
First approved in 2024
Class:
PROTEIN
TISOTUMAB VEDOTIN
MORE DETAILS
T41737F88A
Subunit
1
(448) Similarity Search
Subunit
2
(448) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(448) Similarity Search
Subunit
2
(448) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2021)
First approved in 2021
Class:
PROTEIN
SACITUZUMAB GOVITECAN
MORE DETAILS
M9BYU8XDQ6
Subunit
1
(451) Similarity Search
Subunit
2
(451) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(451) Similarity Search
Subunit
2
(451) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2020)
First approved in 2020
Class:
PROTEIN
TEPROTUMUMAB
MORE DETAILS
Y64GQ0KC0A
Subunit
1
(448) Similarity Search
Subunit
2
(448) Similarity Search
Subunit
3
(215) Similarity Search
Subunit
4
(215) Similarity Search
Export Data
Sequence Search
Subunit
1
(448) Similarity Search
Subunit
2
(448) Similarity Search
Subunit
3
(215) Similarity Search
Subunit
4
(215) Similarity Search
Status:
US Approved Rx (2020)
First approved in 2020
Class:
PROTEIN
TRASTUZUMAB DERUXTECAN
MORE DETAILS
5384HK7574
Subunit
1
(450) Similarity Search
Subunit
2
(450) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(450) Similarity Search
Subunit
2
(450) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2019)
First approved in 2019
Class:
PROTEIN
ENFORTUMAB VEDOTIN
MORE DETAILS
DLE8519RWM
Subunit
1
(447) Similarity Search
Subunit
2
(447) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(447) Similarity Search
Subunit
2
(447) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2019)
First approved in 2019
Class:
PROTEIN
POLATUZUMAB VEDOTIN
MORE DETAILS
KG6VO684Z6
Subunit
1
(447) Similarity Search
Subunit
2
(447) Similarity Search
Subunit
3
(218) Similarity Search
Subunit
4
(218) Similarity Search
Export Data
Sequence Search
Subunit
1
(447) Similarity Search
Subunit
2
(447) Similarity Search
Subunit
3
(218) Similarity Search
Subunit
4
(218) Similarity Search
Status:
US Approved Rx (2019)
First approved in 2019
Class:
PROTEIN
Showing
1 - 10
of
183
results
Search within data set
First page disabled
Previous page disabled
1
2
3
4
18
19
Next page
Next page
